PDF
Full
Outline
To analyze the death status and life loss of patients with severe mental disorders in Wuhan during the period from 2018 to 2022, in order to provide references for formulating bailout management policy for patients with severe mental disorders.
The death data on gender, age, diagnosis, cause of death, and other related information were obtained from the National Information System for Severe Mental Disorders during 2018—2022. Excel 2022 and SPSS 21.0 software were applied to analyze the death characteristics, death cause distribution and mortality. Years of life lost (YLL) and related indicators were used to analyze the life expectancy reduction due to severe mental disorders.
From 2018 to 2022, a total of 3 557 patients with severe mental disorders died in Wuhan, most of them had schizophrenia (2 541 cases, 71.44%). There were more male patients (2 019 cases, 56.76%) than female patients (1 538 cases, 43.24%). The average age of death was 58.06±15.21 years, mainly concentrated in the elderly population over 60 years old (1 719 cases, 48.33%). Significant differences in mortality rates were observed between 2018 and 2022(χ2=58.678, P<0.001), with statistically significant differences found only among patients with schizophrenia (χ2=45.600, P<0.001) and those with mental retardation accompanied by mental disorders (χ2=16.120, P=0.003). Physical diseases were the leading cause of death (2 193 cases, 61.65%). For patients aged 1-69 years, all causes of death resulted in 83 380.75 person-years of potential years of life lost (PYLL), an average years of life lost (AYLL) of 30.71 years, and a potential years of life lost rate (PYLLR) of 173.89%. The greatest total loss of life was caused by schizophrenia, while the highest AYLL was observed for epilepsy with mental disorders (34.08 years).
Severe mental disorders are important diseases that cause life loss, and combined physical diseases are the main cause of death for patients in Wuhan from 2018 to 2022. It is suggested that we should pay more attention to chronic disease management of patients with severe mental disorders, strengthen bailout, and take multiple measures to reduce the risk of death of patients.
PDF
53
24
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62199257
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
